Kewaunee Scientific (NASDAQ:KEQU) VP Elizabeth Phillips Sells 6,880 Shares

Key Points

• Elizabeth Phillips, VP of Kewaunee Scientific, sold 6,880 shares at an average price of $43.20, reducing her ownership in the company by 45.48%.
• Kewaunee Scientific reported a quarterly EPS of $1.10 with a net margin of 4.68% and a revenue of $71.10 million.
• Bank of America and other institutional investors significantly increased their stakes in Kewaunee Scientific, indicating growing interest in the company.

Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) VP Elizabeth Phillips sold 6,880 shares of Kewaunee Scientific stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $43.20, for a total value of $297,216.00. Following the transaction, the vice president directly owned 8,248 shares in the company, valued at approximately $356,313.60. The trade was a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Kewaunee Scientific Trading Down 0.7%

KEQU traded down $0.32 during trading on Thursday, reaching $43.89. The company had a trading volume of 11,021 shares, compared to its average volume of 17,401. Kewaunee Scientific Corporation has a 12-month low of $30.33 and a 12-month high of $71.33. The company has a market cap of $125.95 million, a price-to-earnings ratio of 10.65 and a beta of 0.68. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.63 and a current ratio of 2.32. The firm's 50-day simple moving average is $52.24 and its 200 day simple moving average is $45.34.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last announced its quarterly earnings data on Wednesday, September 10th. The technology company reported $1.10 EPS for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.The firm had revenue of $71.10 million during the quarter.

Analyst Ratings Changes

Separately, Wall Street Zen raised Kewaunee Scientific from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Bank of America Corp DE boosted its stake in Kewaunee Scientific by 2,605.9% in the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock worth $28,000 after purchasing an additional 443 shares in the last quarter. Ritholtz Wealth Management raised its position in shares of Kewaunee Scientific by 42.2% during the first quarter. Ritholtz Wealth Management now owns 17,949 shares of the technology company's stock worth $707,000 after acquiring an additional 5,330 shares during the last quarter. IFP Advisors Inc raised its position in shares of Kewaunee Scientific by 61.5% during the first quarter. IFP Advisors Inc now owns 945 shares of the technology company's stock worth $37,000 after acquiring an additional 360 shares during the last quarter. American Century Companies Inc. raised its position in shares of Kewaunee Scientific by 43.4% during the first quarter. American Century Companies Inc. now owns 49,182 shares of the technology company's stock worth $1,937,000 after acquiring an additional 14,889 shares during the last quarter. Finally, OMERS ADMINISTRATION Corp bought a new stake in shares of Kewaunee Scientific during the first quarter worth $284,000. 32.69% of the stock is currently owned by institutional investors and hedge funds.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.